EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease

Eva Matt, Michael Mitterwallner, Sonja Radjenovic, Daria Grigoryeva, Alexandra Weber, Elisabeth Stögmann, Alina Domitner, Anna Zettl, Sarah Osou, Roland Beisteiner

JAMA Network Open · 26.02.2025 · 8 (2) · e2459170

DOI: 10.1001/jamanetworkopen.2024.59170 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 26.02.2025. Verfasst von Eva Matt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Functional Brain Diagnostics and Therapy, Department of Neurology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Alzheimer Disease, Ultrasonic Therapy, Transcranial Direct Current Stimulation. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Given the increasing prevalence of dementia and the limited treatment options available, ultrasound neuromodulation could serve as a novel add-on therapy to standard treatments for Alzheimer disease (AD). As ultrasound neuromodulation is still in its early stages, further research is essential to fully explore its potential in treating brain disorders.

Objective

To evaluate clinical and functional imaging effects of transcranial pulse stimulation (TPS) in patients with AD. Design, Setting, and Participants A randomized, double-blind, sham-controlled, crossover clinical trial was conducted at the Medical University of Vienna between January 1, 2017, and July 27, 2022. Sixty patients with clinically diagnosed AD receiving state-of-the-art treatment were randomly allocated to treatment sequence groups verum-sham (first cycle verum, second cycle sham, n = 30) and sham-verum (n = 30). Data analysis was performed from July 28, 2022, to September 5, 2024.

Intervention

Each participant received 6 verum and 6 sham TPS sessions (6000 pulses, 0.20 mJ/mm 2 , 5 Hz) to frontoparietal brain areas. Main Outcomes and Measures Neuropsychological tests, including the primary outcome Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) corrected total score (CTS), were performed at baseline and 1 week, 1 month, and 3 months following the stimulations in each cycle. Primary and secondary outcomes, including functional magnetic resonance imaging and Beck Depression Inventory-II, were analyzed by intention-to-treat analysis and, for sensitivity, by per protocol analysis.

Results

For the intention-to-treat analysis, 60 patients between ages 51 and 82 years (mean [SD], 70.65 [8.16] years; 30 females; 30 males) were included. The CERAD CTS increased by a mean (SD) of 2.22 (6.87) points in the verum condition from 70.93 (14.27) points at baseline to 73.15 (14.90) 3 months after stimulation, while the mean (SD) score in the sham condition increased by 1.00 (6.82) point vs baseline from 71.68 (13.62] at baseline to 72.68 (14.48) 3 months after stimulation. Primary data analysis of the condition × session interaction was not significant ( P = .68; partial η 2 [ηp 2 ] = 0.01), but its interaction with age was P = .003; ηp 2 = 0.08, followed by post hoc analyses of age subsamples. Although several patients older than 70 years benefited from verum TPS, only the younger subgroup (≤70 years) showed significantly higher CTS increases for verum in all poststimulation sessions (condition × session: P = .005; ηp 2 = 0.16). At 3 months after stimulation, for example, a mean (SD) 3.91 (7.86)-point increase was found for verum TPS in the younger patients, but a mean (SD) CTS decrease of 1.83 (5.80) was observed for sham. Memory-associated brain activation was significantly higher after verum TPS in the precuneus, visual, and frontal areas, while resting state functional connectivity was significantly upregulated in the dorsal attention network. In the per protocol sample, a significant reduction of the Beck Depression Inventory-II scores 3 months following verum TPS was found (verum baseline: 7.27 [5.87]; verum 3 months after stimulation: 5.27 [5.27]; sham baseline: 6.70 [5.65]; sham 3 months after stimulation: 6.22 [4.40]; P = .008; ηp 2 = 0.23). During both verum and sham conditions, the most common observed adverse symptom was depression; no major neuropathologic change was detected in the patients by detailed neuroradiologic assessments. Conclusions and Relevance In this randomized clinical trial of TPS in patients with AD, a 2-week verum treatment improved cognitive scores in the younger subgroup, ameliorated depressive symptoms, and induced upregulation of functional brain activation and connectivity. These findings suggest TPS may be a safe and promising add-on therapy for patients with AD receiving state-of-the-art treatment. Trial Registration ClinicalTrials.gov Identifier: NCT03770182

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseUltrasonic TherapyTranscranial Direct Current StimulationHumansMaleFemaleAgedDouble-Blind MethodCross-Over StudiesMiddle AgedTreatment OutcomeAged, 80 and overNeuropsychological Tests

Autor:innen und Institutionen

  • Functional Brain Diagnostics and Therapy, Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Memory Outpatient Clinic, Department of Neurology, Medical University of Vienna, Vienna, Austria.

Zitieren

APA

Matt, E., Mitterwallner, M., Radjenovic, S., Grigoryeva, D., Weber, A., Stögmann, E., Domitner, A., Zettl, A., Osou, S., & Beisteiner, R. (2025). Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease. JAMA Network Open, 8(2), e2459170. https://doi.org/10.1001/jamanetworkopen.2024.59170

Vancouver

Matt E, Mitterwallner M, Radjenovic S, Grigoryeva D, Weber A, Stögmann E, et al. Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease. JAMA Network Open. 2025;8(2):e2459170. doi:10.1001/jamanetworkopen.2024.59170

BibTeX
@article{Matt2025,
  author = {Matt, Eva and Mitterwallner, Michael and Radjenovic, Sonja and Grigoryeva, Daria and Weber, Alexandra and Stögmann, Elisabeth and Domitner, Alina and Zettl, Anna and Osou, Sarah and Beisteiner, Roland},
  title = {Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {2},
  pages = {e2459170},
  doi = {10.1001/jamanetworkopen.2024.59170}
}
Kostenlos starten →